Just a thought. I remember in a CC a few months back where the discussion came up about other potential partners (large BP’s) waiting to see the results of the CD12 trial. Possibly NP and other’s are in discussion with those firms in consideration of a partnership. A large firm partnership could help accelerate the entire process of getting our product to market. Manufacturing, packaging, distribution, sales efforts etc. If I was the CEO of CytoDyn I would definitely be considering a partnership that would allow us to maintain control and bring the other resources into play. I believe the FDA and government would welcome an arrangement that would make their approval less risky. Our company has no history of managing all the above so a partnership makes sense, IMO.